Indo-Swiss HealthTech Conclave 2019 on Digital Health was recently conducted in Bengaluru. The Digital Health Conclave (DHC) 2019 put forward a platform curated by swissnex India to showcase cutting-edge technologies and innovations in healthcare from Switzerland and India.
Selected representatives of the Swiss and Indian healthcare sector presented their vision for enhancing the quality of patient-hospital interaction and healthcare delivery at the conclave.
“With this Indo-Swiss Digital Health Conclave, we are establishing a forum for exchange and inspiration on the latest trends, opportunities and challenges with regard to various aspects of digital health. Switzerland is known to be an innovation hub, particularly in medical technologies and pharmaceutical research, while India’s healthtech sector is changing rapidly, creating many opportunities for both countries to collaborate in education, research and innovation”, said Sebastien Hug, CEO of swissnex India and Consul General of Switzerland in India.
The conclave also saw interesting presentations made by the healthcare experts in India. Dr Sailesh Mohan, Joint Director, Public Health Foundation of India (PHFI) talked about the various health technologies developed by PHFI keeping affordability in mind as the prime criteria.
An interactive session between Dr Paul C Salins, Senior VP- NH Narayana Health; Medical Director- Mazumdar Shaw Medical Centre and Dr Shravan Subramanyam, MD, Roche Diagnostics India was quite engaging as the experts spoke about the various challenges facing the healthcare system in India. “India needs to scale up and skill up the healthcare system. The trend is now shifting from treatment to prevention. We stand at a revolutionary period in medical history. An unprecedented convergence of medical knowledge, technology and data science is revolutionising patient care. In order to ensure timely screening, diagnosis, treatment and even prevention of diseases, we need to ensuring the right treatment for the right patient at the right time”, said Dr Shravan. – Bio Pharma Press